These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1498856)
1. CSF noradrenergic activity and sleep EEG in clinically stable schizophrenic patients after haloperidol withdrawal. van Kammen DP; Yao J; Gurklis J; O'Connor D; Nofzinger E; Peters JL Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():325A-326A. PubMed ID: 1498856 [No Abstract] [Full Text] [Related]
2. Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. van Kammen DP; Agren H; Yao JK; O'Connor DT; Gurklis J; Peters JL Am J Psychiatry; 1994 Mar; 151(3):379-84. PubMed ID: 7509126 [TBL] [Abstract][Full Text] [Related]
3. CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal. van Kammen DP; Peters J; van Kammen WB; Nugent A; Goetz KL; Yao J; Linnoila M Biol Psychiatry; 1989 Jun; 26(2):176-88. PubMed ID: 2472177 [TBL] [Abstract][Full Text] [Related]
4. Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients. Neylan TC; van Kammen DP; Kelley ME; Peters JL Arch Gen Psychiatry; 1992 Aug; 49(8):643-9. PubMed ID: 1637254 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia. Forman SD; Bissette G; Yao J; Nemeroff CB; van Kammen DP Schizophr Res; 1994 Apr; 12(1):43-51. PubMed ID: 8018584 [TBL] [Abstract][Full Text] [Related]
6. Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment. Bagdy G; Perényi A; Frecska E; Révai K; Papp Z; Fekete MI; Arató M Psychopharmacology (Berl); 1985; 85(1):62-4. PubMed ID: 2580329 [TBL] [Abstract][Full Text] [Related]
7. [Norepinephrine turnover under neuroleptic treatment of schizophrenic syndromes (author's transl)]. Eben E; Ackenheil M; Rüther E Arzneimittelforschung; 1978; 28(9):1498. PubMed ID: 38809 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs. Hawley RJ; Major LF; Schulman EA; Linnoila M Arch Gen Psychiatry; 1985 Nov; 42(11):1056-62. PubMed ID: 4051683 [TBL] [Abstract][Full Text] [Related]
9. Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free. Nofzinger EA; van Kammen DP; Gilbertson MW; Gurklis JA; Peters JL Biol Psychiatry; 1993 Jun 1-15; 33(11-12):829-35. PubMed ID: 8104041 [TBL] [Abstract][Full Text] [Related]
10. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited. van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140 [TBL] [Abstract][Full Text] [Related]
11. CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships. van Kammen DP; Guidotti A; Kelley ME; Gurklis J; Guarneri P; Gilbertson MW; Yao JK; Peters J; Costa E Biol Psychiatry; 1993 Oct; 34(8):515-22. PubMed ID: 8274578 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia. van Kammen DP; Peters J; van Kammen WB Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272 [TBL] [Abstract][Full Text] [Related]
13. Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Peters JL Arch Gen Psychiatry; 1995 Aug; 52(8):673-8. PubMed ID: 7543265 [TBL] [Abstract][Full Text] [Related]
14. CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships. van Kammen DP; Peters J; Yao J; Neylan T; Beuger M; Pontius E; O'Connor DT Schizophr Res; 1991 Dec; 6(1):31-9. PubMed ID: 1723893 [TBL] [Abstract][Full Text] [Related]
15. Impaired noradrenergic transmission in schizophrenia? van Kammen DP; Antelman S Life Sci; 1984 Apr; 34(15):1403-13. PubMed ID: 6323903 [TBL] [Abstract][Full Text] [Related]